Corbus Pharmaceuticals Holdings, Inc.
CRBP
$8.84
-$0.21-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.94% | -32.16% | -4.03% | -78.15% | 30.86% |
| Total Depreciation and Amortization | -2.00% | -5.66% | -34.57% | -39.55% | -11.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -52.50% | 77.82% | -39.84% | 47.01% | -38.82% |
| Change in Net Operating Assets | -37.77% | 4,951.64% | 112.20% | 60.78% | -25.74% |
| Cash from Operations | -2.39% | 6.32% | -1.08% | -50.07% | 21.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -390.96% | 10.68% | -2.10% | 107.59% | 156.82% |
| Cash from Investing | -390.99% | 10.68% | -2.10% | 107.59% | 156.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 2,515.75% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,515.75% | -- | -- | -- | -100.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.25% | 506.56% | -32.78% | 176.49% | 47.81% |